Progress towards the synthesis of model cyclic phosphonates as putative beta-lactamase inhibitors.

被引：0

作者：

Blecha, J ^{[1
]}

Maung, J ^{[1
]}

Berkman, C ^{[1
]}

机构：

[1] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 225卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

515-CHED

引用

页码：U400 / U400

页数：1

共 50 条

[41] Hepatotoxic reactions induced by beta-lactamase inhibitors
Berg, P
Hahn, EG
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2001, 6 (12) : 535 - 542
[42] INTERACTION OF BETA-LACTAMASE INHIBITORS WITH VARIOUS BETA-LACTAMASES
CULLMANN, W
CHEMOTHERAPY, 1990, 36 (03) : 200 - 208
[43] A short synthesis of an important precursor to a new class of bicyclic beta-lactamase inhibitors
Bellettini, JR
Miller, MJ
TETRAHEDRON LETTERS, 1997, 38 (02) : 167 - 168
[44] SYNTHESIS AND MECHANISTIC EVALUATION OF 7-VINYLIDENECEPHEM SULFONES AS BETA-LACTAMASE INHIBITORS
BUYNAK, JD
KHASNIS, D
BACHMANN, B
WU, KC
LAMB, G
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (24) : 10955 - 10965
[45] EFFECTS OF BETA-LACTAMASE-MEDIATED ANTIMICROBIAL RESISTANCE - THE ROLE OF BETA-LACTAMASE INHIBITORS
MADDUX, MS
PHARMACOTHERAPY, 1991, 11 (02): : S40 - S50
[46] SYNERGISTIC ACTIVITY OF PIPERACILLIN IN COMBINATION WITH BETA-LACTAMASE INHIBITORS
NEU, HC
FU, KP
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (04) : 582 - 585
[47] Combatting Resistant Bacteria with the Help of Beta-Lactamase Inhibitors
Abdel-Magid, Ahmed F.
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (01): : 6 - 7
[48] SYNERGISTIC ACTIVITY OF CEFOPERAZONE IN COMBINATION WITH BETA-LACTAMASE INHIBITORS
FU, KP
NEU, HC
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 7 (03) : 287 - 292
[49] Novel Design of High Affinity Beta-Lactamase Inhibitors
Parekh, Parag A.
Martinez, Eduardo Camacho
Zheng, Shaojiang
Bartlomiej, Fryszczyn
Palzkill, Timothy Gerald
Zu, Youli
FASEB JOURNAL, 2013, 27
[50] Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy
Wong, Darren
van Duin, David
DRUGS, 2017, 77 (06) : 615 - 628

← 1 2 3 4 5 →